103 related articles for article (PubMed ID: 28386843)
1. [Mechanism study on the effect of androgen antagonism in prostate cancer].
Song X; Song Q; Wang R; Zuo QJ; Zhang ZY
Zhonghua Nan Ke Xue; 2023 May; 29(5):402-408. PubMed ID: 38602755
[TBL] [Abstract][Full Text] [Related]
2. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract][Full Text] [Related]
3. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.
Azur RAG; Olarte KCV; Ybañez WS; Ocampo AMM; Bagamasbad PD
PLoS One; 2024; 19(5):e0300413. PubMed ID: 38739593
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.
Sato R; Yamasaki M; Hirai K; Matsubara T; Nomura T; Sato F; Mimata H
Oncol Rep; 2015 Jan; 33(1):58-66. PubMed ID: 25370833
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor signaling regulates T-type Ca
Hall M; Todd B; Allen ED; Nguyen N; Kwon YJ; Nguyen V; Hearne JL; Martin-Caraballo M
Am J Cancer Res; 2018; 8(4):732-747. PubMed ID: 29736318
[TBL] [Abstract][Full Text] [Related]
6. 27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.
Galvan GC; Friedrich NA; Das S; Daniels JP; Pollan S; Dambal S; Suzuki R; Sanders SE; You S; Tanaka H; Lee YJ; Yuan W; de Bono JS; Vasilevskaya I; Knudsen KE; Freeman MR; Freedland SJ
Front Oncol; 2023; 13():1251297. PubMed ID: 38188290
[TBL] [Abstract][Full Text] [Related]
7. Core Structure-Activity Relationship Studies of 5,7,20-
Wu S; Chen G; Chen EY; Farshidpour LS; Zhang Q; Wang G; Chen QH
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111288
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
[TBL] [Abstract][Full Text] [Related]
9. Role of the Dietary Phytochemical Curcumin in Targeting Cancer Cell Signalling Pathways.
Mishra AP; Swetanshu ; Singh P; Yadav S; Nigam M; Seidel V; Rodrigues CF
Plants (Basel); 2023 Apr; 12(9):. PubMed ID: 37176840
[TBL] [Abstract][Full Text] [Related]
10. Strategies to target the cancer driver MYC in tumor cells.
Weber LI; Hartl M
Front Oncol; 2023; 13():1142111. PubMed ID: 36969025
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cells
Ma Y; Ren X; Patel N; Xu X; Wu P; Liu W; Zhang K; Goodin S; Li D; Zheng X
RSC Adv; 2020 Mar; 10(17):10254-10262. PubMed ID: 35498570
[TBL] [Abstract][Full Text] [Related]
12. The Role of Curcumin in Cancer Treatment.
Zoi V; Galani V; Lianos GD; Voulgaris S; Kyritsis AP; Alexiou GA
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572272
[TBL] [Abstract][Full Text] [Related]
13. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.
Abd Wahab NA; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32131560
[TBL] [Abstract][Full Text] [Related]
15. Activation of MAPK and Cyclin D1/CDK4 in Malignant Transformation of Human Embryonic Lung Fibroblasts Induced by Silica and Benzopyrene.
Wang H; Xiao S; Tang Y; Han K; Zhang Z; Jin Y; Shen F
Asian Pac J Cancer Prev; 2020 Feb; 21(2):295-300. PubMed ID: 32102502
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of FRA1 protein in tumors.
Jiang X; Xie H; Dou Y; Yuan J; Zeng D; Xiao S
Mol Biol Rep; 2020 Jan; 47(1):737-752. PubMed ID: 31612408
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status.
Kavya K; Kumar MN; Patil RH; Hegde SM; Kiran Kumar KM; Nagesh R; Babu RL; Ramesh GT; Chidananda Sharma S
Mol Cell Biochem; 2017 Sep; 433(1-2):13-26. PubMed ID: 28386843
[TBL] [Abstract][Full Text] [Related]
18. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.
Chattopadhyay I; Wang J; Qin M; Gao L; Holtz R; Vessella RL; Leach RW; Gelman IH
Oncotarget; 2017 Feb; 8(6):10324-10347. PubMed ID: 28055971
[TBL] [Abstract][Full Text] [Related]
19. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G
Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
